Affix Labs Group B.V., a Green Chemtech startup based in Nijmegen, Netherlands, has raised €1 million in a funding round led by VP Capital and Oost NL.
The company develops water-based, controlled-release insect repellent technology designed to reduce reliance on neurotoxic active ingredients and address rising pesticide resistance. Its flagship product, Repeltec, uses patented solubility and controlled-release systems to create long-lasting insect repellent barriers.
The funding will support Affix Labs’ European rollout, commercial scale-up, and wider distribution in Germany, Austria, France, and Norway. The company also plans to launch a white-label B2B model, allowing partners to integrate its technology into their own product lines.
The round comes as European regulation around chemical pesticides continues to tighten, creating new openings for lower-toxicity alternatives with existing market authorisations.
The company develops water-based, controlled-release insect repellent technology designed to reduce reliance on neurotoxic active ingredients and address rising pesticide resistance. Its flagship product, Repeltec, uses patented solubility and controlled-release systems to create long-lasting insect repellent barriers.
The funding will support Affix Labs’ European rollout, commercial scale-up, and wider distribution in Germany, Austria, France, and Norway. The company also plans to launch a white-label B2B model, allowing partners to integrate its technology into their own product lines.
The round comes as European regulation around chemical pesticides continues to tighten, creating new openings for lower-toxicity alternatives with existing market authorisations.